Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth
Abstract
Tissue-engineered vascular grafts (TEVGs) have the potential to advance the surgical management of infants and children requiring congenital heart surgery by creating functional vascular conduits with growth capacity.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 10, 2022
- Source ID
- 10.1038/s43856-021-00063-7
Entities
People
- Aaron J. Trask
- Abhay B. Ramachandra
- Aimee K Armstrong
- Alison L. Marsden
- Anudari Ulziibayar
- Brian A Boe
- Cameron A Best
- Christopher K. Breuer
- Darren P. Berman
- Drew Musgrave
- Emily Lawson
- Eric D Heuer
- Erica L. Schwarz
- Gabriel J M Mirhaidari
- Hira Ahmad
- Jacob C. Zbinden
- James W. Reinhardt
- Jason M Szafron
- Jason Zakko
- Jay D Humphrey
- John Kelly
- Joseph D Drews
- Kan Hor
- Kejal V. Shah
- Kevin M Blum
- Matthew Wiet
- Megan Heitkemper
- Michael R. Mcdermott
- Rajesh Krishnamurthy
- Ramkumar Krishnamurthy
- Robert S. Daulton
- Ryuma Iwaki
- Shinka Miyamoto
- Stephanie E Lindsey
- Toshiharu Shinoka
- Yu-chun Chang
- Yuichi Matsuzaki
Organizations
- National Heart, Lung, and Blood Institute
- United States Department of Defense
- United States Department of Health and Human Services